Kailera Therapeutics, Inc. KLRA 深 滬
已收盤 07-02 16:00:00 美东时间
21.99
+1.170
+5.62%
華盛通- 最 高22.10
- 今 開20.84
- 成交量 39.23万股
- 最 低 20.745
- 昨 收 20.82
- 總市值 28.49亿
- 52周最高 28.2271
- 市盈率 靜 --
- 換手率 0.30%
- 52周最低 18.50
- 委 比 -48.55%
- 總股本 1.30亿
- 歷史最高 28.2271
- 量 比 0.18
- 振 幅 6.51%
- 歷史最低 18.50
- 每 手 1
- 風險率 2.13%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Kailera Therapeutics Q1 EPS $(3.65) Misses $(0.68) Estimate as R&D Spend Jumps to $70.9M
Kailera Therapeutics (NASDAQ:KLRA) reported quarterly losses of $(3.65) per share which missed the analyst consensus estimate of $(0.68) by 444.78 percent as R&D spend Jumps to $70.9M.
05-27 04:50
This Weight-Loss Drug Challenger Could Follow Eli Lilly's Playbook: Analyst
William Blair gives Kailera Therapeutics ($KLRA) an Outperform rating. Learn why analysts see a competitive edge in their GLP-1 assets.
05-14 02:43
美股大行评级 | 富国银行上调英伟达目标价从265美元升至315美元；Alamar、AEVEX获多家大行首予“买入”评级
今日重点评级关注：Needham：维持Artiva Biotherapeutics"买入"评级，目标价从18美元升至41美元；HC Wainwright & Co.：维持SAB Biotherapeutics"买入"评级，目标价从7美元升至10美元
05-13 11:46
JP Morgan Initiates Coverage On Kailera Therapeutics with Overweight Rating, Announces Price Target of $30
JP Morgan analyst Hardik Parikh initiates coverage on Kailera Therapeutics (NASDAQ:KLRA) with a Overweight rating and announces Price Target of $30.
05-12 22:29
Kailera Therapeutics shares are trading higher amid post-IPO volatility.
Kailera Therapeutics shares are trading higher amid post-IPO volatility.
04-20 22:56
美股收盘：纳指13连涨！追平1992年以来最长连涨纪录；大型科技股悉数走强，特斯拉涨超3%，苹果涨超2%
伊朗开放霍尔木兹海峡，纳指涨超1.5%录得13连涨！追平1992年以来最长连涨纪录；大型科技股悉数走强，特斯拉涨超3%，苹果涨超2%；稀土概念股CRML大涨超35%>>
04-18 09:07
募资6.25亿美元创五年之最 减肥药新贵Kailera Therapeutics(KLRA.US)今晚登陆纳斯达克
Kailera Therapeutics Inc.通过扩大首次公开发行(IPO)规模，成功募资6.25亿美元，创下2021年以来美国生物科技领域规模最大的IPO纪录。
04-17 11:33
减肥药公司Kailera Therapeutics(KLRA.US)IPO定价14-16美元/股 拟周五登陆纳斯达克
Kailera Therapeutics于周一公布其首次公开募股(IPO)条款。
04-14 15:19
UPDATE 1-Kailera, Alamar launch US IPOs as biotech listings gather momentum
UPDATE 1-Kailera, Alamar launch US IPOs as biotech listings gather momentum Changes media packaging code to USA-IPO/BIOTECH, adds details on Kailera and Alamar IPOs throughout April 13 (Reuters) - Alamar Biosciences and Kailera Therapeutics kicked off roadshows for their U.S. initial public offering
04-13 19:58
